(2020). A perspective on erythropoietin as a potential adjuvant therapy for acute lung injury/acute respiratory distress syndrome in patients with covid-19.
Chicago Style (17th ed.) CitationA Perspective on Erythropoietin as a Potential Adjuvant Therapy for Acute Lung Injury/acute Respiratory Distress Syndrome in Patients with Covid-19. 2020.
MLA (8th ed.) CitationA Perspective on Erythropoietin as a Potential Adjuvant Therapy for Acute Lung Injury/acute Respiratory Distress Syndrome in Patients with Covid-19. 2020.
Warning: These citations may not always be 100% accurate.